Device
Sham tSMS
Sham tSMS is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
unknownnot_applicable
Manual Dexterity Modifications After Application of tSMS Over the Primary Motor Cortex (M1)
NCT05260190
unknownnot_applicable
Transcranial Static Magnetic Field Stimulation (tSMS) in Amyotrophic Lateral Sclerosis (ALS).
NCT04393467
completednot_applicable
Transcranial Static Magnetic Field Stimulation of Frontal Cortex
NCT03244501
Clinical Trials (3)
Showing 3 of 3 trials
NCT05260190Not Applicable
Manual Dexterity Modifications After Application of tSMS Over the Primary Motor Cortex (M1)
NCT04393467Not Applicable
Transcranial Static Magnetic Field Stimulation (tSMS) in Amyotrophic Lateral Sclerosis (ALS).
NCT03244501Not Applicable
Transcranial Static Magnetic Field Stimulation of Frontal Cortex
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3